+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Automated Biochemistry Analyzers Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Fully Automated Biochemistry Analyzers, Semi-Automated Biochemistry Analyzers), By Technology (Ion-Selective Electrode , Colorimetric Technology, Electrochemical Technology, Fluorescent Technology, Mass Spectrometry), By Configuration (Bench-Top Analyzers, Floor-Standing Analyzers), By Application (Clinical Diagnostics, Bioreactor Byproduct Detection, Drug Development & Research Applications), By End-User (Hospitals & Clinical Laboratories, Diagnostic Centers, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Point-of-Care Testing) Companies, and Country Forecast, 2021 to 2034

Global Automated Biochemistry Analyzers Market size is forecast to increase from $9.78 Billion in 2026 to $23.03 Billion in 2034 at a CAGR of 11.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005777
Pages: 224 Pages

Automated and Closed Cell Therapy Processing Systems Market Size, Share and Growth Outlook, 2026: Analysis By Workflow (Apheresis, Separation, Expansion, Fill-Finish, Cryopreservation), By Product Type (Stem Cell Therapy Systems, Non-Stem Cell Therapy Systems), By Scale (Pre-commercial Scale, Commercial Scale), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Academic Medical Centers, Contract Development & Manufacturing Organizations) Companies, and Country Forecast, 2021 to 2034

Global Automated and Closed Cell Therapy Processing Systems Market size is forecast to increase from $2.34 Billion in 2026 to $9.22 Billion in 2034 at a CAGR of 18.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005776
Pages: 221 Pages

Automated Analyzers Market Size, Share and Growth Outlook, 2026: Analysis By Analyzer (Biochemistry Analyzers, Immuno-based , Hematology Analyzers, Urine & Coagulation Analyzers), By Modality (Standalone , Modular , Point-of-Care ), By Application (Clinical Diagnostics, Drug Discovery & Development, Genomics & Proteomics, Bioanalysis & Analytical Chemistry), By End-User (Hospital and Commercial Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic Medical Centers & Research Institutions) Companies, and Country Forecast, 2021 to 2034

Global Automated Analyzers Market size is forecast to increase from $11.58 Billion in 2026 to $29.92 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005775
Pages: 227 Pages

Autologous Wound Patches Market Size, Share and Growth Outlook, 2026: Analysis By Type (Platelet-Rich Fibrin , Platelet-Rich Plasma , Autologous Whole-Blood Clot Patches ), By Application (Chronic Wounds , Acute Wounds ), By End-Use (Hospitals, Specialized Wound Care Clinics, Ambulatory Surgical Centers , Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Autologous Wound Patches Market size is forecast to increase from $116.66 Million in 2026 to $325.84 Million in 2034 at a CAGR of 13.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005774
Pages: 217 Pages

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Autologous Stem Cell Therapies , Autologous Non-Stem Cell Therapies , Platelet-Rich Plasma ), By Application (Oncology, Orthopedics & Musculoskeletal Disorders, Cardiology, Neurology , Dermatology & Wound Healing, Autoimmune Disorders), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers , Stem Cell Banks and Research Facilities) Companies, and Country Forecast, 2021 to 2034

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market size is forecast to increase from $7.32 Billion in 2026 to $24.67 Billion in 2034 at a CAGR of 16.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005773
Pages: 220 Pages

Autologous Matrix-induced Chondrogenesis Market Size, Share and Growth Outlook, 2026: Analysis By Material Type (Collagen-based Matrices, Hyaluronic Acid-based Matrices, Synthetic Polymer Matrices, Composite & Hybrid Matrices), By Application (Knee Cartilage Repair, Hip Cartilage Repair, Ankle, Others), By Procedure Type (Open Surgery AMIC, Arthroscopic AMIC), By End User (Hospitals, Ambulatory Surgical Centers , Specialty Orthopedic Clinics) Companies, and Country Forecast, 2021 to 2034

Global Autologous Matrix-induced Chondrogenesis Market size is forecast to increase from $255.32 Million in 2026 to $494 Million in 2034 at a CAGR of 8.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005772
Pages: 215 Pages

Autologous Cell Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Chimeric Antigen Receptor , Tumor-Infiltrating Lymphocyte , T-cell Receptor , Hematopoietic Stem Cell , Natural Killer ), By Source (Bone Marrow-derived, Peripheral Blood-derived, Adipose Tissue-derived), By Application (Oncology , Neurology, Cardiology, Orthopedics & Regenerative Medicine, Autoimmune Disorders), By End User (Hospitals & Specialty Centers, Academic & Research Institutes, Biopharmaceutical Companies) Companies, and Country Forecast, 2021 to 2034

Global Autologous Cell Therapy Market size is forecast to increase from $7.5 Billion in 2026 to $35.15 Billion in 2034 at a CAGR of 21.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005771
Pages: 210 Pages

Autoinjectors Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Prefilled Autoinjectors, Fillable), By Type of Device (Disposable Autoinjectors, Reusable Autoinjectors), By Activation Mechanism (Mechanical , Motor-Driven Autoinjectors, Manual-Assist Autoinjectors), By Technology (Conventional Autoinjectors, Smart), By Therapeutic Area (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes, Obesity), By End User (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Autoinjectors Market size is forecast to increase from $9.72 Billion in 2026 to $28.92 Billion in 2034 at a CAGR of 14.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005770
Pages: 227 Pages

Autoimmune Hemolytic Anemia Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Corticosteroids, Immunosuppressive Therapy, Biologic Therapy, Intravenous Immunoglobulin , Blood Transfusion Support, Targeted Novel Therapies), By Disease Type (Warm Autoimmune Hemolytic Anemia , Cold Agglutinin Disease , Paroxysmal Cold Hemoglobinuria , Drug-Induced Immune Hemolytic Anemia), By Application Setting (Hospital-Based Management, Outpatient Management), By End-User (Hospitals & Specialty Hematology Units, Diagnostic Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Autoimmune Hemolytic Anemia Market size is forecast to increase from $912.86 Million in 2026 to $1545.16 Million in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005769
Pages: 211 Pages

Autoimmune Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Biologics , Immunosuppressants, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs , Targeted Small Molecule Therapies), By Indication (Rheumatic Diseases, Multiple Sclerosis, Inflammatory Bowel Disease , Dermatology Indications , Type 1 Diabetes), By Route of Administration (Oral, Parenteral ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online & Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Autoimmune Drugs Market size is forecast to increase from $114.8 Billion in 2026 to $195.78 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005768
Pages: 214 Pages